1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2
2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Multiple Myeloma (Kahlers Disease) - Pipeline Review, H2
2012, provides an overview of the indication’s therapeutic pipeline. This report
provides information on the therapeutic development for Multiple Myeloma
(Kahlers Disease), complete with latest updates, and special features on late-stage
and discontinued projects. It also reviews key players involved in the therapeutic
development for Multiple Myeloma (Kahlers Disease). Multiple Myeloma (Kahlers
Disease) - Pipeline Review, Half Year is built using data and information sourced
from Global Markets Direct’s proprietary databases, Company/University websites,
SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by
Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Multiple Myeloma (Kahlers
Disease).
2. - A review of the Multiple Myeloma (Kahlers Disease) products under development
by companies and universities/research institutes based on information derived
from company and industry-specific sources.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Multiple Myeloma (Kahlers Disease).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
Table of contents:
List of Tables 8
List of Figures 13
Introduction 14
Global Markets Direct Report Coverage 14
Multiple Myeloma (Kahlers Disease) Overview 15
Therapeutics Development 16
An Overview of Pipeline Products for Multiple Myeloma (Kahlers Disease) 16
Multiple Myeloma (Kahlers Disease) Therapeutics under Development by
Companies 18
Multiple Myeloma (Kahlers Disease) Therapeutics under Investigation by
Universities/Institutes 27
Late Stage Products 39
Comparative Analysis 39
Mid Clinical Stage Products 40
Comparative Analysis 40
Early Clinical Stage Products 41
Comparative Analysis 41
Discovery and Pre-Clinical Stage Products 42
Comparative Analysis 42
Multiple Myeloma (Kahlers Disease) Therapeutics – Products under Development
by Companies 43
Multiple Myeloma (Kahlers Disease) Therapeutics – Products under Investigation by
Universities/Institutes 56
3. Companies Involved in Multiple Myeloma (Kahlers Disease) Therapeutics
Development 87
Bristol-Myers Squibb Company 87
Johnson & Johnson 88
Kyowa Hakko Kirin Co., Ltd. 89
Abbott Laboratories 90
Amgen Inc. 91
Eli Lilly and Company 92
Viralytics Ltd. 93
GlaxoSmithKline plc 94
Seattle Genetics, Inc. 95
Genentech, Inc. 96
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012
Respiratory Depression – Pipeline Review, H2 2012
Metastatic Cancer – Pipeline Review, H2 2012
Viral Infections – Pipeline Review, H2 2012
4. Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012
Gastrointestinal Tract Cancer – Pipeline Review, H2 2012
Diabetes – Pipeline Review, H2 2012
Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,
H2 2012
Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012
Malaria – Pipeline Review, H2 2012
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,
H2 2012
Dermatitis – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya